Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
GLP-1 Receptor Agonists | Incretin-Based Therapy GLP-1 receptor agonists are synthetic analogs of human GLP-1 that provide pharmacologic incretin effects, improving glycemic control while supporting weight loss and cardiovascular benefits
No mandatory cycling protocol is required
Blend Composition TB-500 Thymosin 4 Fragment 10mg BPC-157 Gastric Pentadecapeptide 10mg GHK-Cu Copper Tripeptide 50mg KPV -MSH Tripeptide 10mg Reference data KLOW Blend specifications Composition 10mg TB-500 + 10mg BPC-157 + 50mg GHK-Cu + 10mg KPV Total amount per vial 80mg co-lyophilized blend Components Four research peptides Appearance White to pale blue lyophilized powder (copper content) Solubility Soluble in bacteriostatic water Purity 99.41% Research applications Where KLOW Blend is used in research Areas of study described in the published literature
You are not a lesser being than your doctor
This finding strongly supports the necessity of RAMP1 and RAMP3 for mediating cagrilintide-induced weight loss through AMY1R and AMY3R signaling [2]
US$ 7118.19
Sold : Login>>
